A retrospective multi-institution training study using 267 ER+ breast cancer cases (see Methods section) was carried out to examine GP88 IHC scores and determine a GP88 cut-off score for defining high and low GP88 expression groups. The gene discussed is ESR1; the disease is breast carcinoma.